The Weekly Litigation News Digest is now live. Subscribe now

Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts - EP2588090

The patent EP2588090 was granted to Krka on Nov 22, 2023. The application was originally filed on Jul 1, 2011 under application number EP11732405A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2588090

KRKA
Application Number
EP11732405A
Filing Date
Jul 1, 2011
Status
Patent Maintained As Amended
Oct 20, 2023
Publication Date
Nov 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EDERJan 19, 2018EDERADMISSIBLE
GEORG KALHAMMERSTEPHAN TEIPELJan 19, 2018-ADMISSIBLE
GENERICS UKJan 16, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO03074056
DESCRIPTIONWO2005018615
DESCRIPTIONWO2005023249
DESCRIPTIONWO2005028468
DESCRIPTIONWO2009118321
DESCRIPTIONWO2009118322
DESCRIPTIONWO2010007016
DESCRIPTIONWO9837075
INTERNATIONAL-SEARCH-REPORTWO2009097156
INTERNATIONAL-SEARCH-REPORTWO2010007016
OPPOSITIONUS2003181488
OPPOSITIONWO03074056
OPPOSITIONWO2009097156
OPPOSITIONWO2010007016
OTHERWO2009097156
OTHERWO2010007016

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents